Cost Effectiveness of Primary Radiotherapy Versus Radical Prostatectomy for Intermediate-to-High Risk Prostate Cancer

The quality-adjusted life expectancy was higher for patients with intermediate to high-risk prostate cancer after radiation and androgen deprivation therapy (RT + ADT) by 0.5 to 1.14 quality-adjusted life years, compared to radical prostatectomy (RP) and adjuvant RT for risk factors, with fewer patients experiencing single or multiple treatment-related toxicities. RT + ADT may result in improved outcomes compared to RP for intermediate-to-high risk prostate cancer.

http://ift.tt/2gxZHLA